Recent submissions

Comment · 10 days ago
Comment · 11 days ago
Hearsay from a single person about being denied a Barclays account for who knows what reason (banks never give a reason, to stop you from re-applying and getting round their KYC rules). From a suspect publication I've never heard of and very little info on the internet, linking to another 'Originally Published In' similar unheard of with little info publication. Submitted by OP with little post history and only from this site? I'd take this article with a large pinch of salt.
Comment · 18 days ago
Comment · 1 month ago
I would probably phrase it as 'Go grandmaster Shin defeats two-stone-handicapped AI KataGo'
Comment · 1 year ago
Comment · 2 years ago
Comment · 2 years ago
Self-checkouts, like many problems, seemed to be solved when I visited Japan. They have 3 stations, 1 where an employee scans your items and then puts them back into a new basket. They then direct you towards (one of many) terminals where you pay. There are then more spaces where you can bag your groceries.

Once you've seen it you'll be baffled as to why it isn't a global solution. No need for the employee or others to wait while you count your coins or bag up, and no need for anyone to wait behind you while you wait for the self-service checkout to weigh each item individually, fail to scan etc.

Comment · 4 years ago
Balanced out by the centripetal force of the plane turning!
Comment · 5 years ago
Comment · 5 years ago
Comment · 5 years ago
The demand for a Tesla at $25K is going to be huge. Given previous manufacturing delays, I wouldn't expect them to anywhere near keep up. Therefore although they could sell at $25K, due to the insane demand they may as well sell at $30K to reduce some demand, and then bring it down to $25K over a year or 2 as they work through those willing to pay a higher price.
Comment · 5 years ago
Comment · 5 years ago
Page 8 of https://www.cogconsortium.uk/wp-content/uploads/2020/12/Repo... hints towards this.

The short answer is that 'The extent to which SARS-CoV-2 may evolve to escape immunity induced by infection or vaccination is not currently known'. However analysis has been carried out to work out how far from the receptor-binding site the mutations are, and how 'antibody-accessible' these are, with a few such as . No conclusions are drawn from this analysis.

Earlier on in the report (towards the end of page 1), this statement is given `One of these (the N501Y mutation) occurs in the region of the Spike protein, the receptor binding domain (RBD), that the virus uses to bind to the human ACE2 receptor. Changes in this region of the Spike protein can result in the virus changing its ACE2 binding specificity and alter antibody recognition`.

Saying all this, vaccines are designed to create a range of antibody responses, in order to stop this very fear of a single mutation rendering a whole vaccine useless. [https://www.nature.com/articles/d41586-020-02544-6] I also recall reading somewhere that adapting the vaccine to account for a mutation (much like is done yearly with the flue vaccine) is relatively easy, though I haven't managed to find that article again yet.

Comment · 5 years ago
For those (like me) who are looking for some more details of this new strain, I found 2 papers from the `COVID-19 Genomics Consortium UK (CoG-UK)` of great interest. It seems like the prime reasons for concern are increased frequency of mutations, increased proportion of cases, and possible change in immune response

> Several aspects of this cluster are noteworthy for epidemiological and biological reasons and we report preliminary findings below. In summary: The B.1.1.7 lineage accounts for an increasing proportion of cases in parts of England. The number of B.1.1.7 cases, and the number of regions reporting B.1.1.7 infections, are growing. B.1.1.7 has an unusually large number of genetic changes, particularly in the spike protein. Three of these mutations have potential biological effects that have been described previously to varying extents:

> - Mutation N501Y is one of six key contact residues within the receptor-binding domain (RBD) and has been identified as increasing binding affinity to human and murine ACE2.

> - The spike deletion 69-70del has been described in the context of evasion to the human immune response but has also occurred a number of times in association with other RBD changes.

> - Mutation P681H is immediately adjacent to the furin cleavage site, a known location of biological significance.

> The rapid growth of this lineage indicates the need for enhanced genomic and epidemiological surveillance worldwide and laboratory investigations of antigenicity and infectivity.

https://www.cogconsortium.uk/wp-content/uploads/2020/12/Repo...

https://virological.org/t/preliminary-genomic-characterisati...

Live from the official Hacker News API

A modern reader for Hacker News · SvelteKit + Skeleton